Ever wondered how a country decides the price of new medicines? Spain has been working on an update to how it evaluates and prices drugs for its National Health System (NHS). They've got a plan that stretches from 2019 to 2024. The Advisory Committee on Pharmaceutical Financing (CAPF) has shared some recommendations to make this process more efficient and fair. Firs...
Lawmakers have been questioning Novo Nordisk, the company behind popular weight loss drugs Ozempic and Wegovy. The Senate wants to know why these medications are priced so much higher in the U.S. compared to other countries. For example, Americans with diabetes pay $969 per month for Ozempic, while Canadians pay just $155. The CEO of Novo Nordisk, Lars Fruergaard Jør...
Imagine a world where drugs cost differently based on where you live. That's what happened at a recent Senate hearing in Washington, D.C. Novo Nordisk's CEO, Lars Fruergaard Jorgensen, was asked some tough questions about the high prices of two important medications: Ozempic for diabetes and Wegovy for weight loss. Jorgensen blamed pharmacy benefit managers (PBMs) f...